A novel integrative computational framework for breast cancer radiogenomic biomarker discovery

[Display omitted] •Bayesian tensor factorization is used to integrate multiomics data for radiogenomics analysis.•A regression framework is proposed to handle the unmatched data issue in radiogenomics analysis.•Deep learning is used to identify prognostic meaningful radiogenomic biomarkers for cance...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Computational and structural biotechnology journal 2022-01, Vol.20, p.2484-2494
Hauptverfasser: Liu, Qian, Hu, Pingzhao
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[Display omitted] •Bayesian tensor factorization is used to integrate multiomics data for radiogenomics analysis.•A regression framework is proposed to handle the unmatched data issue in radiogenomics analysis.•Deep learning is used to identify prognostic meaningful radiogenomic biomarkers for cancer. In precise medicine, it is with great value to develop computational frameworks for identifying prognostic biomarkers which can capture both multi-genomic and phenotypic heterogeneity of breast cancer (BC). Radiogenomics is a field where medical images and genomic measurements are integrated and mined to solve challenging clinical problems. Previous radiogenomic studies suffered from data incompleteness, feature subjectivity and low interpretability. For example, the majority of the radiogenomic studies miss one or two of medical imaging data, genomic data, and clinical outcome data, which results in the data incomplete issue. Feature subjectivity issue comes from the extraction of imaging features with significant human involvement. Thus, there is an urgent need to address above-mentioned limitations so that fully automatic and transparent radiogenomic prognostic biomarkers could be identified for BC. We proposed a novel framework for BC prognostic radiogenomic biomarker identification. This framework involves an explainable DL model for image feature extraction, a Bayesian tensor factorization (BTF) processing for multi-genomic feature extraction, a leverage strategy to utilize unpaired imaging, genomic, and survival outcome data, and a mediation analysis to provide further interpretation for identified biomarkers. This work provided a new perspective for conducting a comprehensive radiogenomic study when only limited resources are given. Compared with baseline traditional radiogenomic biomarkers, the 23 biomarkers identified by the proposed framework performed better in indicating patients’ survival outcome. And their interpretability is guaranteed by different levels of build-in and follow-up analyses.
ISSN:2001-0370
2001-0370
DOI:10.1016/j.csbj.2022.05.031